Vanity, Thy Name Is Growth
Earnings growth at a reasonable price is getting hard to find in this market after a 10%-plus rally since June. Third-quarter earnings estimates have come down significantly over the last few months and domestic GDP will be lucky to come in at a 2% level for the year. Maybe it is because I live in Miami, the cosmetic surgery capital of the country, but I find two suppliers to that business intriguing right now. One I already own and the other I am looking to pick up on the next market pullback. Neither is currently making money, but both are experiencing rapid revenue growth, have cash-rich balance sheets, should turn profitable in the near future and have very strong growth prospects ahead of them.
Cynosure (CYNO) develops aesthetic treatment systems to the dermatology, plastic surgery, and general medical markets. Its aesthetic treatment systems incorporate a range of laser and other light-based energy sources....399 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.
